Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
226.1 USD | -0.87% | -3.13% | -3.60% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.60% | 11.75B | |
+24.43% | 44.96B | |
+1.59% | 42.65B | |
+46.11% | 41.85B | |
-4.27% | 29.04B | |
+11.48% | 26.08B | |
-20.41% | 19.03B | |
+7.02% | 12.75B | |
+28.43% | 12.06B | |
+21.23% | 11.72B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- TD Cowen Cuts Charles River Laboratories' Price Target to $209 From $212, Maintains Market Perform Rating